# Yuyu Pharma Explores Animal Health as a New Pathway for Human Drug Innovation

- Link: https://www.thailand-business-news.com/pr-news/yuyu-pharma-explores-animal-health-as-a-new-pathway-for-human-drug-innovation
- Published: 2026-10-29T20:00:00+07:00
- Author: PR Newswire

|   |

SEOUL, South Korea, Oct. 29, 2026 /PRNewswire/ — Yuyu Pharma (KRX: 000220) CEO Robert
Wonsang Yu shared the company’s vision for connecting human and animal health at
BIOPLUS-INTERPHEX KOREA 2026 (BIX 2026), highlighting how pharmaceutical research
and development can create new opportunities across both markets.

Speaking during a panel discussion titled **"One Pipeline, Two Markets: Dual Commercialization
Strategies Through Animal Health,"** Robert explored how pharmaceutical companies
can leverage their existing technologies, scientific expertise, and drug development
capabilities to pursue opportunities in both human and veterinary medicine.

The discussion brought together pharmaceutical and biotechnology leaders to examine
emerging business opportunities, regulatory considerations, investment trends, and
the potential for global partnerships in animal health.

For Yuyu Pharma, the strategy represents a natural extension of its pharmaceutical
heritage. Founded in 1941, Yuyu has spent 85 years building expertise in pharmaceuticals
and healthcare. Today, the company is exploring new growth opportunities in biotechnology,
animal health, and emerging drug development technologies.

The **"One Pipeline, Two Markets"** approach recognizes that certain technologies
and scientific insights developed for human medicine may also have applications 
in veterinary medicine. Conversely, research conducted in animal health may generate
valuable insights that inform future human drug discovery and development.

"Companion animal pharmaceuticals offer an opportunity to build additional experience
and capabilities in drug development," said Robert. "We believe that scientific 
insights gained through veterinary drug development may also contribute to future
research in human medicine."

Robert also emphasized the importance of the One Health perspective, which recognizes
the connections among human, animal, and environmental health.

"Human and animal health are more closely connected than we often realize," Robert
added. "Our long-term vision is to explore how innovation can move in both directions—
from human medicine to animal health, and potentially from animal health back to
human medicine."

As the global companion animal healthcare market continues to evolve, advances in
biotechnology, drug delivery, and pharmaceutical research are creating new opportunities
for companies with experience in human medicine.

Yuyu Pharma sees animal health as an opportunity to apply its existing pharmaceutical
capabilities in a new market while building knowledge, partnerships, and development
experience that may support future innovation. For an 85-year-old pharmaceutical
company, the strategy reflects a broader commitment to exploring new technologies,
entering new markets, and finding new ways to improve health.

**About Yuyu Pharma**

Founded in 1941, Yuyu Pharma (KRX: 000220) is a South Korean pharmaceutical company
engaged in the development, manufacturing, and commercialization of pharmaceuticals
and healthcare products.

Building on 85 years of experience, Yuyu continues to explore new opportunities 
in biotechnology, animal health, and emerging healthcare businesses through initiatives
including Yuyu Bio and Yuyu Venture Studio.

---

  |  This article was produced by Cision PR Newswire, our trusted news partner. The views expressed and the content presented here are solely those of the author and may not fully reflect the opinions of Thailand Business News. |

---

 
**Read the original article :** [Yuyu Pharma Explores Animal Health as a New Pathway for Human Drug Innovation ](http://www.prnasia.com/story/archive/5084483_CN84483_0?rand=184833)